Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 18:16:2735-2745.
doi: 10.2147/PRBM.S414553. eCollection 2023.

Effect of the Online Mindfulness-Based Stress Reduction on Anxiety and Depression Status of COVID-19 Patients Treated in Fangcang Hospitals: A Randomized Controlled Trial

Haowei Li #  1 , Hao Chen #  2   3 , Zifeng Ye  4 , Xuehang Li  1 , Lei Yang  1   5 , Shengshu Wang  1 , Shanshan Yang  6 , Shaohua Liu  1 , Shimin Chen  1 , Rongrong Li  1 , Junhan Yang  1   3 , Huaihao Li  1 , Yinghui Bao  1 , Yueting Shi  1   3 , Jianhua Wang  1 , Yao He  1   7 , Miao Liu  3
Affiliations

Effect of the Online Mindfulness-Based Stress Reduction on Anxiety and Depression Status of COVID-19 Patients Treated in Fangcang Hospitals: A Randomized Controlled Trial

Haowei Li et al. Psychol Res Behav Manag. .

Abstract

Background: As the focal point of epidemic prevention and control, the mental health of COVID-19 patients cannot be ignored. Online Mindfulness-Based Stress Reduction (MBSR) allows for the provision of conveniently accessible, effective and low-cost interventions on a large scale. We aim to evaluate the effectiveness of an online MBSR intervention in alleviating anxiety and depression among asymptomatic/mild patients limited by COVID-19-related restrictions.

Methods: Fifty-eight patients treated in Sanya Fangcang hospital were randomly allocated to either to the experimental group (n = 29) following daily, for 5 days, an online-based mindfulness intervention or to the control group (n = 29). Patients from both groups underwent online questionnaires including assessment of anxiety and depression status at pre- and post-tests using Self-rating Anxiety Scale and Self-Rating Depression Scale.

Results: After the online-based MBSR program, the anxiety and depression scores of the patients in the MBSR group decreased significantly in comparison to the scores of those in the control group (respectively η2 = 0.175, η2 = 0.215, p < 0.001). And the proportion of severe anxiety and depression patients in the MBSR group decreased to 0% which lower than the control group, and the proportion of light anxiety and depression patients was significantly more than that in the control group after the MBSR intervention.

Conclusion: The online-based MBSR intervention appears to be an effective way of alleviating anxiety and depression symptoms among COVID-19 patients with associated quarantine in Fangcang hospital. Given the seriousness of mental health threat that could be posed by this ongoing pandemic, our study provides a new idea and method for cost-effective and time-efficient interventions in the future of epidemic prevention and control.

Keywords: COVID-19 patients; anxiety; depression; online mindfulness; psychological intervention.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flow diagram of study participants.
Figure 2
Figure 2
The distribution of participants in the different levels for both the MBSR and control groups at pre- and post-tests.
See this image and copyright information in PMC

References

    1. Yazaki S, Yoshida T, Kojima Y, et al. Difference in SARS-CoV-2 antibody status between patients with cancer and health care workers during the COVID-19 pandemic in Japan. JAMA Oncol. 2021;7(8):1141–1148. doi: 10.1001/jamaoncol.2021.2159 - DOI - PMC - PubMed
    1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/. Accessed January 10, 2023.
    1. Cai W, Yang Z, Liang J, et al. How fast and how well the Omicron epidemic was curtailed. A Guangzhou experience to share. Front Public Health. 2022;10:979063. doi: 10.3389/fpubh.2022.979063 - DOI - PMC - PubMed
    1. Tzitzi E, Pyrpasopoulou A, Kalmoukos P, et al. Casivirimab/Imdevimab effect on COVID-19 outcome and reinfection in a real-world SARS-COV-2 variant transition period setting. Monoclon Antib Immunodiagn Immunother. 2023;42:48–50. doi: 10.1089/mab.2022.0033 - DOI - PubMed
    1. Aleem A, Akbar Samad AB, Slenker AK. Emerging variants of SARS-CoV-2 and novel therapeutics against Coronavirus (COVID-19). In: StatPearls. Treasure Island: StatPearls Publishing LLC; 2022. - PubMed